China NMPA Product Recall - Hip prostheses - ceramic femoral heads and liners, femoral heads and revised acetabular cups, hip prostheses

On April 13, 2015, Zimmer (Shanghai) Medical International Trading Co., Ltd. initiated a voluntary global recall of various hip joint prostheses, including Ceramic Femoral Heads and Liners, Femoral Heads, and Revision Acetabular Cups. The recall was prompted by a critical issue identified by the manufacturer, Zimmer GmbH: a potential risk of packaging damage that could compromise the sterile state of the products. This violation poses a significant safety concern for patients undergoing primary or revision hip surgeries, as it could lead to infections or other adverse events. The affected products, manufactured by Zimmer GmbH, were subject to recall under the oversight of the National Medical Products Administration (NMPA) of China, previously known as the National Food and Drug Administration (FDA) in China, as indicated by their import permits. The recall in China alone involved a substantial quantity of medical devices, with 1924 units imported and 1814 units manufactured for the Chinese market. As a mandatory corrective action, all identified affected products have been successfully recalled from distribution and returned to the manufacturer, Zimmer GmbH, to mitigate any further risks to patient health and ensure compliance with medical device safety standards.